There is uncertainty regarding the optimal duration of androgen deprivation therapy with postoperative radiation in prostate cancer. We seek to provide clarity through our interpretation of the RADICALS‐HD trial.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: